Purchase Order HT942523P0016
Award Date 3/6/23
Potential Completion Date 3/6/27
Potential Value $132K
Federal Agency
Ultimate Awardee
NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Waltham, MA 02451, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed price purchase order was awarded by the Department of the Army Medical Command to Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC. The contract is for the provision of ChemDraw software and related subscriptions, with a potential value of $107,511.00. The contract does not have a set-aside designation and is set to expire on February 6, 2023. Revvity Signals Software has a history of providing a range of informatics...
- The Defense Health Agency awarded a $76,525 firm fixed-price purchase order to Revvity Signals Software, Inc. on September 30, 2024, for Signal Image Artist Software with an ultimate completion date of September 29, 2029. This contract, which includes no small business set-aside designation, will be performed in Frederick, Maryland. Revvity Signals Software is a subsidiary of Revvity Inc. and specializes in scientific informatics software solutions for federal research institutions, with its...
- The U.S. Office of Naval Research awarded a $14,440.00 firm-fixed-price purchase order to Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC, for the provision of ChemDraw software. This contract has a period of performance through March 6, 2025. Revvity Signals Software specializes in providing scientific informatics software solutions to support biomedical research initiatives across various federal agencies, including the NIH, DOD, EPA,...
- This is a firm-fixed price purchase order awarded by the National Institutes of Health (NIH) to Revvity Signals Software, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC. The contract is for the provision of a 2-year departmental license for ChemBioDraw Ultra software, a chemical structure drawing and analysis tool, for the National Institute of Allergy and Infectious Diseases (NIAID). The total ceiling value of the contract is $17,444.00. This purchase order does not have a set-aside...
- The Office of Naval Research awarded a $3,290 firm fixed-price purchase order to Revvity Signals Software, Inc. for software on February 20, 2014, with completion scheduled for March 6, 2014. The contract, which was not set aside for small businesses, was performed in Waltham, Massachusetts. Revvity Signals Software, a subsidiary of Revvity Inc. and part of the Medical Imaging, LLC Division, is a scientific informatics software provider specializing in tools that support biomedical research...
- Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC, has been awarded a $14,655 firm fixed price purchase order by the National Institute on Drug Abuse, a component of the National Institutes of Health within the Department of Health and Human Services. The contract calls for the delivery of CHEMDraw and Signals Notebook software to support scientific research efforts. Place of performance is Baltimore, Maryland. The one-year contract period...
- This firm-fixed price purchase order, valued at $6,250.00, was awarded by the Air Force Research Laboratory (AFRL) to Revvity Signals Software, Inc., a subsidiary of Revvity Inc. Medical Imaging, LLC, for the renewal of ChemDraw software licenses. The contract does not have a set-aside designation. Revvity Signals Software is a leading provider of scientific informatics software solutions to the U.S. federal government, including products such as ChemOffice, ChemDraw, Signals Notebook, and...
- The U.S. Drug Enforcement Administration (DEA) awarded a $28,540.65 firm-fixed-price purchase order to Revvity Signals Software, Inc. Informatics Division, a subsidiary of Revvity Inc. Medical Imaging, LLC. The contract is for the provision of ChemOffice+ Cloud Standard software licenses and ChemDraw JS add-on licenses for a one-year performance period from March 13, 2023, to March 12, 2024. This award does not utilize a set-aside designation. Revvity Signals Software is a leading provider of...
- This firm-fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), is for a $11,725 license and support contract for Revvity Signals Software, Inc.'s scientific informatics products. The contract includes ChemOffice, ChemDraw, Signals Notebook, and Columbus data visualization software, which are used to support biomedical research and scientific computing across various federal...
- This is a firm-fixed price purchase order worth $16,880.00 awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Revvity Signals Software, Inc. The contract is for the provision of software licenses and subscriptions for products such as ChemOffice Professional, ChemDraw, E-Notebook Enterprise, and Columbus Server, as well as associated installation, training, maintenance, and support services. Revvity Signals...
The Defense Health Agency awarded a purchase order to Revvity Signals Software, Inc. for chemical structure drawing software valued at $131,621.40 on March 6, 2023. Performance is located in Waltham, Massachusetts. The order carries a firm fixed price, with ultimate completion scheduled for March 6, 2027. No small business set-aside was used.
Generated 6/2/26, 9:50 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $26.5k | 3/2/26 | |
| P00002 | Exercise an Option | $26.5k | 3/5/25 | |
| P00001 | Exercise an Option | $25.3k | 3/5/24 | |
| Not listed | Not listed | $24.1k | 3/6/23 |